Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05973656

Role of Acetaldehyde in the Development of Oral Cancer

Dissecting the Role of Acetaldehyde in Oral Carcinogenesis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
Masonic Cancer Center, University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primarily non-invasive biological samples at various time points. Biospecimens to be collected include saliva, oral cells collected via mouthwash and cheek brush, and urine. The collection of two blood samples (5 mL each) will be optional and banked for future use.

Conditions

Interventions

TypeNameDescription
DRUGAlcoholAlcohol dose given orally that will result in a 0.03% blood alcohol concentration (BAC).
PROCEDUREBiospecimen CollectionUndergo saliva, mouthwash, and cheek brush collection
PROCEDUREBreath TestUndergo breathalyzer testing

Timeline

Start date
2022-07-08
Primary completion
2026-11-30
Completion
2027-09-30
First posted
2023-08-03
Last updated
2025-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05973656. Inclusion in this directory is not an endorsement.